Company / Working Capital per Share
Syndax Pharmaceuticals Inc Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.76
FY2025
5-year range
$4.76 / $8.93
FY2021-FY2025
Trend
-19.2%
vs FY2024
Sector context
#111 of 210
Health Care
What the data says
At $4.76, Syndax Pharmaceuticals Inc's working capital per share ranks #111 of 210 in the Health Care sector. Working Capital per Share has declined for 5 consecutive years, from $10.32 in FY2020 to $4.76 in FY2025.
Based on SEC 10-K filings.
4.76 in FY2025 with a 5-year CAGR of -14.3%.
Declined from $7.68 to $4.76 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -17.2%
- 5-Year CAGR
- -14.3%
- 10-Year CAGR
- -
Sector benchmark
#111 of 210 in Health CareTop 53% of 210This company $4.76 Sector average $146.86
▼
-96.8% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's working capital per share has declined for 5 consecutive years.
- In FY2025, working capital per share decreased 19.2% year-over-year.
- Ranks #111 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.76 | -19.2% |
| FY2024 | $5.89 | -23.3% |
| FY2023 | $7.68 | -8.4% |
| FY2022 | $8.38 | -6.2% |
| FY2021 | $8.93 | -13.4% |
| FY2020 | $10.32 | +482.8% |
| FY2019 | $1.77 | -35.8% |
| FY2018 | $2.76 | -57.3% |
| FY2017 | $6.46 | -99.4% |
| FY2016 | $1148.69 | -5.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026